NEW YORK (GenomeWeb) – Interpace Diagnostics reported today that its first quarter revenues rose 43 percent year over year, thanks in part to 60 percent growth in the number of tests accessioned.

For the quarter ended March 31, the molecular diagnostics developer reported revenues of $3.0 million compared to revenues of $2.1 million the year before.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.